Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional CD32 molecules on human NK cells.

P A Morel1, L K Ernst, D Metes

  • 1Department of Medicine, University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute, PA 15213, USA. morel+@pitt.edu

Leukemia & Lymphoma
|October 8, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapamycin augments human DC IL-12p70 and IL-27 secretion to promote allogeneic Type 1 polarization modulated by NK cells.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same author

Investigation of lymphocyte depletion and repopulation using alemtuzumab (Campath-1H) in cynomolgus monkeys.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2010
Same author

[Realization pathways of prolactin modulating influence on the cAMP-dependent mechanism of meiosis regulation in bovine oocytes].

Tsitologiia·2009
Same author

Contribution of naïve and memory T-cell populations to the human alloimmune response.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
Same author

[Cytogenetic and immunological specificity of mammalian hybrid cell lines].

Tsitologiia·2007
Same author

EBV-specific CD8+ T cell reactivation in transplant patients results in expansion of CD8+ type-1 regulatory T cells.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2007
Same journal

Glofitamab for the treatment of relapsed/refractory hairy cell leukemia: a case report.

Leukemia & lymphoma·2026
Same journal

Pre- and post-transplant serum albumin levels and outcomes after allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia.

Leukemia & lymphoma·2026
Same journal

Leukemia mortality analysis in the pediatric population in São Paulo state, Brazil, 2000-2019.

Leukemia & lymphoma·2026
Same journal

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Leukemia & lymphoma·2026
Same journal

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

Leukemia & lymphoma·2026
Same journal

D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.

Leukemia & lymphoma·2026
See all related articles

Human Natural Killer (NK) cells can now be found to express an additional Fc gamma receptor II (FcγRII), CD32. This novel finding suggests potential clinical applications for tumor immunotherapy and autoimmune disease treatment.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Human Natural Killer (NK) cells are large granular lymphocytes crucial for innate immunity.
  • NK cell cytotoxicity is primarily mediated by perforin-dependent mechanisms.
  • Antibody-dependent cell-mediated cytotoxicity (ADCC) is triggered by Fc gamma receptor III (FcγRIII, CD16) binding IgG.

Purpose of the Study:

  • To characterize the novel Fc gamma receptor II (FcγRII, CD32) found on human NK cells.
  • To investigate the molecular, biochemical, and functional features of this newly identified NK cell receptor.

Main Methods:

  • Molecular characterization of FcγRII on NK cells.
  • Biochemical analysis of FcγRII function.
  • Functional assays to assess NK cell activity mediated by FcγRII.

Related Experiment Videos

Main Results:

  • Demonstrated the presence of a functional Fc gamma receptor II (FcγRII, CD32) on human NK cells.
  • Detailed the molecular, biochemical, and functional properties of this novel receptor.

Conclusions:

  • The expression of FcγRII (CD32) on NK cells represents a significant discovery in cellular immunology.
  • The presence of functional FcγRII on NK cells may have important clinical implications for tumor immunotherapy and the management of autoimmune diseases.